TCL Archive Dasatinib, Nilotinib Show Strong Early Results As Frontline Therapy For CML December 28, 2007
TCL Archive Trial In Metastatic Disease To Be Unblinded After Regorafenib Meets Primary Endpoint November 25, 2011
TCL Archive Advisors Approve $50 Million NCI Effort To Attack Cancer On a Molecular Level July 2, 1999